Kenza Health Hub logoGet Started
1 May 2026Injectable drugsSource update: March 2024

Phytomenadione Injectable: Dosing and Precautions

Vitamin K1 guidance for prophylaxis and treatment of haemorrhagic disease of the newborn.

Also searched as

Phytomenadione injectableVitamin K1 injectable
Prescription under medical supervision

Source reviewed

March 2024

Guide category

Injectable drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Vitamin, anti-haemorrhagic.

Indications

Prophylaxis and treatment of haemorrhagic disease of the newborn.

Forms and strengths, route of administration

  • 2 mg ampoule (10 mg/ml, 0.2 ml) for oral administration, IM injection, or slow IV injection.

Dose

Prophylaxis of haemorrhagic disease of the newborn

By IM route on the day of birth:

  • Neonate under 1.5 kg: 0.5 mg single dose.
  • Neonate 1.5 kg and over: 1 mg single dose.

Treatment of haemorrhagic disease of the newborn

By IM or slow IV route:

  • 1 mg every 8 hours if necessary, depending on clinical evolution and coagulation test results.

Contra-indications, adverse effects, precautions

  • May cause allergic reactions, especially by IV route, and haematoma at IM injection site.
  • Pregnancy and breast-feeding: no contra-indication.
  • Also comes in 10 mg ampoules for use in adults only, for example in treatment of haemorrhage due to antivitamin K agents.
  • Vitamin K1 is also used as prophylaxis for neonatal hypoprothrombinaemia in mothers treated with enzyme-inducing antituberculosis drugs during pregnancy: administer 10 mg/day orally for 15 days before birth.
  • This maternal prevention does not change the need for IM administration of vitamin K in neonates.
  • Do not dilute or mix with other drugs in the same syringe.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.